Jing Zou Selected Research

Labyrinth Diseases

12/2015	Postaurical injection is a systemic delivery supported by symmetric distribution of Gd-DOTA in both the ipsilateral and contralateral ears.
7/2014	Pathway and morphological transformation of liposome nanocarriers after release from a novel sustained inner-ear delivery system.
2/2014	The predominant vestibular uptake of gadolinium through the oval window pathway is compromised by endolymphatic hydrops in Ménière's disease.
2/2011	Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
12/2010	Manufacturing and in vivo inner ear visualization of MRI traceable liposome nanoparticles encapsulating gadolinium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jing Zou Research Topics

Disease

33	Neoplasms (Cancer) 01/2022 - 07/2006
13	Hearing Loss (Hearing Impairment) 12/2017 - 12/2003
12	Infections 12/2022 - 12/2012
12	COVID-19 01/2022 - 03/2020
10	Carcinogenesis 11/2020 - 08/2011
9	Inflammation (Inflammations) 11/2022 - 11/2016
8	Parkinson Disease (Parkinson's Disease) 01/2019 - 01/2013
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2012
7	Dental Caries (Decay, Dental) 10/2019 - 04/2005
6	Endolymphatic Hydrops 10/2020 - 12/2003
6	Meniere Disease (Menieres Disease) 12/2019 - 12/2010
5	Zika Virus Infection 01/2021 - 02/2017
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 06/2012
5	Dengue (Dengue Fever) 01/2020 - 01/2014
5	Prostatic Neoplasms (Prostate Cancer) 01/2016 - 10/2011
5	Labyrinth Diseases 12/2015 - 12/2010
4	Leukemia 01/2021 - 01/2016
4	Virus Diseases (Viral Diseases) 01/2021 - 03/2015
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 08/2014
4	Ovarian Neoplasms (Ovarian Cancer) 11/2020 - 08/2014
4	Carcinoma (Carcinomatosis) 10/2020 - 12/2012
4	Vertigo (Positional Vertigo) 12/2019 - 01/2013
4	Sensorineural Hearing Loss 12/2017 - 01/2008
4	Adenocarcinoma 01/2015 - 08/2011
3	Pain (Aches) 05/2022 - 08/2019
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2016
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2020 - 01/2016
3	Dental Plaque 12/2019 - 10/2006
3	Lymphoma (Lymphomas) 03/2019 - 08/2007
3	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2018 - 01/2017
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 01/2009
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017 - 01/2016
3	Otitis Media 09/2016 - 12/2014
3	Amyopathic dermatomyositis 01/2016 - 08/2014
3	Intervertebral Disc Degeneration 01/2015 - 01/2014
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2014 - 08/2011
2	Cognitive Dysfunction 09/2022 - 01/2020
2	Burns 05/2022 - 01/2015
2	Ischemic Stroke 01/2022 - 01/2020
2	Stomatitis 01/2022 - 01/2021
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 01/2021
2	Head and Neck Neoplasms (Head and Neck Cancer) 12/2021 - 05/2021
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2021 - 01/2021
2	Hypoxia (Hypoxemia) 09/2021 - 07/2010
2	Dysbiosis 01/2021 - 01/2019
2	Hyperglycemia 01/2021 - 01/2018
2	Neuralgia (Stump Neuralgia) 01/2021 - 08/2019
2	Postherpetic Neuralgia 01/2021 - 08/2019
2	Yellow Fever 07/2020 - 11/2018
2	Fever (Fevers) 06/2020 - 12/2012
2	Communicable Diseases (Infectious Diseases) 01/2020 - 10/2018

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 09/2021 - 07/2006
15	VaccinesIBA 12/2022 - 01/2013
10	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2013
9	Biomarkers (Surrogate Marker)IBA 09/2021 - 08/2011
9	ZincIBA 01/2016 - 08/2011
8	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2015
8	Pharmaceutical PreparationsIBA 12/2019 - 10/2008
7	Biological ProductsIBA 11/2020 - 01/2008
5	EnzymesIBA 01/2021 - 01/2015
5	CytokinesIBA 01/2021 - 01/2018
5	GadoliniumIBA 12/2019 - 12/2003
5	zinc-binding protein (zinc binding protein)IBA 10/2014 - 10/2011
4	Therapeutic UsesIBA 12/2021 - 10/2020
4	Leucine (L-Leucine)FDA Link 09/2021 - 04/2014
4	Retinaldehyde (Retinal)IBA 01/2021 - 01/2015
4	AntibodiesIBA 01/2021 - 09/2020
4	Transcription Factors (Transcription Factor)IBA 11/2020 - 07/2010
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2020 - 04/2005
4	SilverIBA 12/2016 - 12/2014
4	Contrast MediaIBA 01/2013 - 12/2003
3	Tyrosine Kinase InhibitorsIBA 01/2022 - 12/2018
3	CollagenIBA 12/2021 - 01/2015
3	Peptides (Polypeptides)IBA 05/2021 - 10/2015
3	Hormones (Hormone)IBA 07/2019 - 04/2014
3	Beclin-1IBA 03/2019 - 01/2014
3	3-nitropropionic acidIBA 07/2012 - 01/2009
3	Calcitriol Receptors (Calcitriol Receptor)IBA 07/2009 - 01/2008
2	BNT162 VaccineIBA 12/2022 - 01/2021
2	Immunoglobulin A (IgA)IBA 11/2022 - 11/2021
2	Neutralizing AntibodiesIBA 01/2022 - 11/2021
2	Photosensitizing Agents (Photosensitizers)IBA 01/2022 - 01/2022
2	Caspase 3 (Caspase-3)IBA 11/2021 - 01/2008
2	ImmunosorbentsIBA 01/2021 - 01/2015
2	Immunoglobulin M (IgM)IBA 01/2021 - 02/2017
2	Monoclonal AntibodiesIBA 01/2021 - 08/2020
2	Serine (L-Serine)FDA Link 01/2021 - 01/2008
2	AntagomirsIBA 01/2021 - 01/2018
2	SteroidsIBA 12/2020 - 06/2019
2	Circular RNAIBA 12/2020 - 09/2020
2	Transient Receptor Potential ChannelsIBA 12/2020 - 01/2008
2	Glycerol (Glycerine)FDA LinkGeneric 10/2020 - 01/2018
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2020 - 10/2015

Therapy/Procedure

20	Therapeutics 01/2022 - 10/2008
7	Drug Therapy (Chemotherapy) 01/2022 - 08/2014
6	Electroacupuncture 01/2022 - 01/2014
4	Lasers (Laser) 01/2022 - 12/2013
3	Radiotherapy 01/2022 - 01/2021
3	Immunotherapy 01/2022 - 01/2022
2	Oral Diagnosis (Oral Examination) 01/2021 - 08/2020